Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 14;36(14):2047-2060.
doi: 10.15252/embj.201796664. Epub 2017 Jun 12.

RPA activates the XPF-ERCC1 endonuclease to initiate processing of DNA interstrand crosslinks

Affiliations

RPA activates the XPF-ERCC1 endonuclease to initiate processing of DNA interstrand crosslinks

Ummi B Abdullah et al. EMBO J. .

Abstract

During replication-coupled DNA interstrand crosslink (ICL) repair, the XPF-ERCC1 endonuclease is required for the incisions that release, or "unhook", ICLs, but the mechanism of ICL unhooking remains largely unknown. Incisions are triggered when the nascent leading strand of a replication fork strikes the ICL Here, we report that while purified XPF-ERCC1 incises simple ICL-containing model replication fork structures, the presence of a nascent leading strand, modelling the effects of replication arrest, inhibits this activity. Strikingly, the addition of the single-stranded DNA (ssDNA)-binding replication protein A (RPA) selectively restores XPF-ERCC1 endonuclease activity on this structure. The 5'-3' exonuclease SNM1A can load from the XPF-ERCC1-RPA-induced incisions and digest past the crosslink to quantitatively complete the unhooking reaction. We postulate that these collaborative activities of XPF-ERCC1, RPA and SNM1A might explain how ICL unhooking is achieved in vivo.

Keywords: RPA; Fanconi anaemia; SNM1A; XPF‐ERCC1; interstrand crosslinks.

PubMed Disclaimer

Figures

Figure EV1
Figure EV1. Purification and validation of nuclease activity of human recombinant XPF‐ERCC1 (XE)
  1. Purified XPF‐ERCC1 (XE) analysed on an SDS–PAGE gel (4–12%) stained with InstantBlue (left‐hand panel) and Western blot analysis (right‐hand panel). WT = wild type XE; D676A = XE mutated to substitute aspartic acid residue 676 of XPF with alanine.

  2. Nuclease activity of WT and D676A forms of XE on a “simple fork” substrate. The substitution of metal‐binding residue in XPF (D676A) renders the XE complex devoid of any nuclease activity. Red circles denote 3′[32P]‐radiolabelled nucleotides.

  3. (Top panel) Nuclease activity of XE on a “simple fork” substrate over a time course. (Bottom panel) Quantification of intact substrate and incision products expressed as a percentage of initial substrate as in top panel, n = 2.

Figure 1
Figure 1. Nascent leading strands on replication fork structures inhibit XPFERCC1 (XE) activity
  1. Nuclease activity of XE on “fork‐like” DNA substrates (simple fork; +leading strand; +lagging strand; +leading and +lagging strands). The red circles denote 3′[32P]‐radiolabelled nucleotides. “M” denotes molecular weight marker.

  2. A schematic representation of XE incisions on a “simple fork” and “+leading‐strand” substrates. The positions of incision with respect to the fork junctions are indicated in bold (2 or 6 nt from the fork junction), and size of 3′[32P]‐labelled incision products and percentage of incisions are indicated in parentheses.

  3. Quantification of total substrate incisions expressed as a percentage of initial substrate as in (B). Unpaired two‐tailed t‐test; **P < 0.01. Error bars represent SEM, n = 3.

  4. Nuclease activity of XE on fork substrates with increasing length of a model nascent leading strand (simple fork; −9; −3; −2; −1; 0 nt from the fork junction).

  5. A schematic representation of XPF‐ERCC1 incisions as in (D).

  6. Quantification of intact substrate and incision products expressed as a percentage of initial substrate at 40 nM XE as in (D). Error bars represent SEM, n = 3.

Figure EV2
Figure EV2. 5′‐radiolabelling of the DNA substrates reveals additional minor incisions by XPF‐ERCC1, within the duplex region
(Top panel) Nuclease activity of XE on the indicated fork substrates. Green circles denote 5′[32P]‐radiolabelled nucleotides. (Bottom panel) A schematic representation of the position of XE incisions: the positions of incision relative to the fork junction are indicated in bold and the size of 5′[32P]‐labelled incision products is indicated in parentheses.
Figure EV3
Figure EV3. RPA specifically stimulates XPF‐ERCC1 activity on the strand with a 3′‐ssDNA arm of a fork structure and its stimulation requires a minimum of 23 nucleotides ssDNA arms
  1. The nuclease activity of XE in the presence and absence of RPA on fork substrates 3′[32P]‐radiolabelled either on the “top” or the “bottom” strand. XPF‐ERCC1 activity is not detectable on the bottom strand of the fork substrates, which have a 5′‐ssDNA arm.

  2. The nuclease activity of XE in the presence and absence of RPA on simple fork substrates containing arms of 23, 13 or 3 nucleotides.

Source data are available online for this figure.
Figure 2
Figure 2. Inhibition of XE activity by a model nascent leading strand is overcome by the addition of RPA
  1. Nuclease activity of XE on a “simple fork” with increasing concentration of RPA or SSB (Escherichia coli).

  2. Quantification of intact substrate and incision products as a percentage of initial substrate as in (A). Error bars represent SEM, n = 3.

  3. A schematic representation of 40 nM XE activity on a “simple fork” in the absence (left) or presence (right) of 80 nM RPA.

  4. Nuclease activity of XE on fork substrates with increasing length of a model nascent leading strand (simple fork; −9; −3; −2; −1; 0 nt from the fork junction) in the presence or absence of 80 nM RPA.

  5. A schematic representation of XE activity in the presence and absence of RPA as in (D).

Figure EV4
Figure EV4. RPA stimulation of XPF‐ERCC1 activity on “+leading‐strand” structure is not attributed to the displacement of the model nascent leading strand or the unwinding of the fork substrates by RPA
  1. Nuclease activity of XE on the indicated fork substrates in the presence or absence of RPA. RPA specifically stimulates XE activity on a “simple fork” and “+leading‐strand” substrates.

  2. Fluorescence anisotropy assay to determine the binding constants of RPA for either “simple fork” or “+lagging‐strand” substrates. The blue diamonds denote the fluorophore‐labelled nucleotides. Error bars represent SD, n = 3.

  3. (Top panel) Outline of potential consequences of incubating “+leading‐strand” substrate radiolabelled on the model nascent leading strand with RPA, and the potential products that might be revealed by analysis on a non‐denaturing PAGE gel. (Bottom panel) Nuclease activity performed as in panel a. Reaction products were separated on a 10% non‐denaturing PAGE gel. The DNA substrates remain intact in the RPA alone reactions (lanes 4 and 9), indicating that RPA does not displace the model nascent leading strand or unwind the fork substrates, at the concentrations employed.

Source data are available online for this figure.
Figure 3
Figure 3. RPA stimulates XPFERCC1 activity by binding to the 5′ arms of a DNA fork substrate
  1. Fluorescence anisotropy assay to determine the binding constants of RPA for either “simple fork” or “+leading‐strand” substrates. The blue diamonds denote the fluorophore‐labelled nucleotides.

  2. Nuclease activity of XE on “+leading strand” or DNA:RNA hybrid (5′ ssRNA on the bottom strand) substrates in the presence or absence of 80 nM RPA. RPA cannot stimulate XE to overcome the inhibition of a model nascent leading strand when the 5′‐ssDNA overhang is replaced with 5′ ssRNA. Green line denotes RNA.

  3. (Top panel) Nuclease activity of XE on “+leading‐strand” substrate in the presence or absence of either the WT RPA or the truncated RPA (RPA70C442). (Bottom panel) A schematic representation of the structural domains of WT RPA and RPA70C442. Purple boxes represent the DNA‐binding domains (DBD) designated as A–F. The orange box represents the winged helix domain. RPA70, RPA32 and RPA14 denote the three subunits of RPA.

  4. Limited proteolysis assay to determine structural changes in RPA in the presence or absence of the indicated substrates. 800 nM RPA was incubated with 100 nM unlabelled DNA substrates (simple fork; +leading strand; or no DNA) prior to digestion with 500 nM trypsin in a time course. Reaction samples were separated in Bis‐Tris SDS–PAGE (4–12%) and stained with InstantBlue. Red arrows indicated tryptic digestion pattern of RPA.

Figure 4
Figure 4. A model nascent leading strand also inhibits XE activity on a fork structure containing a single triazole interstrand crosslink (ICL), but the presence of RPA overcomes this inhibition
  1. Sequence and schematic structure of a “simple fork” containing a single triazole ICL at the fork junction and its predicted XE nuclease incision products when radiolabelled on the 5′‐end, based on the data obtained on non‐crosslinked fork structure in Figs 1, 2, 3, 4. Green circles denote 5′[32P]‐radiolabelled nucleotides.

  2. (Top panel) Nuclease activity of XE on 3′[32P]‐labelled crosslinked simple fork substrate. (Bottom panel) A schematic representation of the nuclease reaction and the incision products.

  3. (Top panel) Nuclease activity of XE on 5′[32P]‐labelled model native (lanes 2 and 3) and crosslinked (lanes 4 and 5) DNA substrates. The XE incision closest to the fork junction (2 nt from the junction, 26‐mer product) is inhibited in the presence of a crosslink at the fork junction (lane 5). (Bottom panel) Schematic representation of the nuclease reaction and its incision products.

  4. Nuclease activity of XE on 3′[32P]‐radiolabelled crosslinked substrate (simple fork; +leading strand) in the presence or absence of 80 nM RPA. XPF‐ERCC1 incisions reduced by a leading strand are overcome by the presence of RPA (compare lane 5 to lane 6).

Figure EV5
Figure EV5. Generation of triazole‐containing crosslinked substrates
Scheme of copper‐catalysed click ligation between alkyne and azide oligonucleotides to form DNA interstrand crosslink (ICL) substrate.
Figure 5
Figure 5. The 5′–3′ exonuclease SNM1A can load from an incision induced by XPFERCC1 to digest past a crosslink
  1. (Top panel) Nuclease activity of XE on “simple fork” and +leading‐strand substrates in the presence or absence of RPA and further incubated with 0.8 nM SNM1A in a time course. (Bottom panel) Schematic representation of the nuclease assay reaction products. The blue arrow denotes incision by XE and green Pacman represents digestion by SNM1A. RPA does not affect/alter SNM1A exonuclease activity as seen in the similar stepwise digestion products of SNM1A in the presence or absence of RPA (lanes 2–9). However, the presence of a model leading strand prevents SNM1A from loading onto XE‐RPA‐induced incisions to digest the DNA substrate (lanes 10–17).

  2. (Top panel) Nuclease activity of XE‐RPA on crosslinked DNA substrates (simple fork; +leading strand) and further incubation with SNM1A in a time course. SNM1A digestion inhibition by a model nascent leading strand (as in A) is overcome when an ICL is located at the fork junction.

Figure 6
Figure 6. Model for the collaborative activity of XPFERCC1, RPA and SNM1A to unhook a crosslink
  1. When a single replication fork encounters an ICL, the nascent leading strand initially stalls 20–40 nt from the ICL (“−20” position; step a‐i). It gradually progresses to 1 nt from the ICL (“0” position; step a‐ii), and its arrival at the ICL triggers an XPF‐ERCC1‐RPA‐induced incision six nucleotides 5′ to the junction, in a duplex region (step a‐iii). SNM1A loads from these incisions and digests past the ICL, unhooking the ICL from the DNA duplex, leaving a residual single nucleotide moiety (step a‐iv), which has been demonstrated as the reaction product using mass spectrometry to characterise the reaction products of SNM1A activity in previous work (Wang et al, 2011). This enables translesion synthesis to occur and repair of the broken DNA strand via homologous recombination (step a‐v).

  2. In the event of dual replication fork convergence onto an ICL, both nascent leading strands initially stall ˜20–40 nt from the ICL (step b‐i). CMG complexes from both replication forks unload from both leading strands, as previously described (Long et al, 2014; Zhang et al, 2015) which enables one nascent leading strand to gradually progresses to 1 nt from the ICL (“0” position; step b‐ii) as previously described (Raschle et al, 2008; Zhang et al, 2015). The structure that arises at this stage is inhibitory for XPF‐ERCC1. However, in the presence of RPA, XPF‐ERCC1 will be able to incise the structure (on the lagging‐strand template associated with the fork which has progressed to 0 nt) within the duplex region, 6 nt from the ICL (step b‐iv). This XPF‐ERCC1‐RPA‐induced incision enables SNM1A to load onto and digest past the ICL (step b‐v). The net result of XPF‐ERCC1‐RPA‐SNM1A is ICL unhooking, which enable the translesion (TLS) synthesis step, where the strand extended by the TLS polymerase is the nascent leading strand which remained arrested at ˜20–40 nt from the ICL on the second converged fork and did not strike the ICL (step b‐vi). Homologous recombination‐based repair of the broken chromatid completes repair and facilitates fork restart.

Data information: Black dotted arrows represent initial approach by nascent leading strands. Blue arrows represent incisions by XPF‐ERCC1; green dotted arrows represent digestion by SNM1A; maroon dotted arrows represent nascent leading strand progression.

Comment in

References

    1. Allerston CK, Lee SY, Newman JA, Schofield CJ, McHugh PJ, Gileadi O (2015) The structures of the SNM1A and SNM1B/Apollo nuclease domains reveal a potential basis for their distinct DNA processing activities. Nucleic Acids Res 43: 11047–11060 - PMC - PubMed
    1. Bessho T, Sancar A, Thompson LH, Thelen MP (1997) Reconstitution of human excision nuclease with recombinant XPF‐ERCC1 complex. J Biol Chem 272: 3833–3837 - PubMed
    1. Bhagwat N, Olsen AL, Wang AT, Hanada K, Stuckert P, Kanaar R, D'Andrea A, Niedernhofer LJ, McHugh PJ (2009) XPF‐ERCC1 participates in the Fanconi anemia pathway of cross‐link repair. Mol Cell Biol 29: 6427–6437 - PMC - PubMed
    1. Brosh RM Jr, Bellani M, Liu Y, Seidman MM (2017) Fanconi Anemia: a DNA repair disorder characterized by accelerated decline of the hematopoietic stem cell compartment and other features of aging. Ageing Res Rev 3: 67–75 - PMC - PubMed
    1. Budzowska M, Graham TG, Sobeck A, Waga S, Walter JC (2015) Regulation of the Rev1‐pol zeta complex during bypass of a DNA interstrand cross‐link. EMBO J 34: 1971–1985 - PMC - PubMed

LinkOut - more resources